  {
  "head": {
    "vars": [ "outcomeUid" , "studyDataTypeUri" , "studyDataTypeLabel" , "instanceUid" , "groupLabel" , "sampleSize" , "count" , "mean" , "std" , "momentUid" , "relativeToAnchor" , "timeOffset" , "duration" , "relativeToEpochLa
      bel" ]
  } ,
  "results": {
    "bindings": [
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a21b3d3c-2c83-42c4-b0ef-c1f29eff0411" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/06bce411-f887-41b0-8cb6-3aa74d728c7c" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP 12-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "223" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.440000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.360000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a21b3d3c-2c83-42c4-b0ef-c1f29eff0411" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/06bce411-f887-41b0-8cb6-3aa74d728c7c" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP 12-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "290" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.540000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.510000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a21b3d3c-2c83-42c4-b0ef-c1f29eff0411" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/06bce411-f887-41b0-8cb6-3aa74d728c7c" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP 12-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "227" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.480000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.290000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a21b3d3c-2c83-42c4-b0ef-c1f29eff0411" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/06bce411-f887-41b0-8cb6-3aa74d728c7c" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP 12-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "278" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.690000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.500000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a21b3d3c-2c83-42c4-b0ef-c1f29eff0411" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/06bce411-f887-41b0-8cb6-3aa74d728c7c" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP 12-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "219" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.080000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.290000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a21b3d3c-2c83-42c4-b0ef-c1f29eff0411" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/06bce411-f887-41b0-8cb6-3aa74d728c7c" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP 12-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "281" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.210000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.550000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/647828a0-f751-47d6-9da6-0e370ece9d39" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/cd4d02da-30dc-49c2-8bda-7e2dec10aefe" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP 24-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "223" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.390000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "7.620000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/647828a0-f751-47d6-9da6-0e370ece9d39" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/cd4d02da-30dc-49c2-8bda-7e2dec10aefe" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP 24-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "290" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.510000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "7.660000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/647828a0-f751-47d6-9da6-0e370ece9d39" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/cd4d02da-30dc-49c2-8bda-7e2dec10aefe" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP 24-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "227" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.440000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "7.680000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/647828a0-f751-47d6-9da6-0e370ece9d39" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/cd4d02da-30dc-49c2-8bda-7e2dec10aefe" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP 24-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "278" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.640000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "7.670000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/647828a0-f751-47d6-9da6-0e370ece9d39" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/cd4d02da-30dc-49c2-8bda-7e2dec10aefe" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP 24-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "219" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.050000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "7.700000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/647828a0-f751-47d6-9da6-0e370ece9d39" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/cd4d02da-30dc-49c2-8bda-7e2dec10aefe" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP 24-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "281" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.200000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "7.710000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/6ac27cf8-e64b-4bf8-9f99-a8df066d879c" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/b853ec27-702b-4be4-b439-a964e9ffd106" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP daytime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "223" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.420000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "7.910000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/6ac27cf8-e64b-4bf8-9f99-a8df066d879c" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/b853ec27-702b-4be4-b439-a964e9ffd106" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP daytime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "290" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.530000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.000000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/6ac27cf8-e64b-4bf8-9f99-a8df066d879c" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/b853ec27-702b-4be4-b439-a964e9ffd106" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP daytime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "227" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.470000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "7.990000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/6ac27cf8-e64b-4bf8-9f99-a8df066d879c" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/b853ec27-702b-4be4-b439-a964e9ffd106" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP daytime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "278" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.660000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.000000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/6ac27cf8-e64b-4bf8-9f99-a8df066d879c" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/b853ec27-702b-4be4-b439-a964e9ffd106" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP daytime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "219" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.070000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "7.990000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/6ac27cf8-e64b-4bf8-9f99-a8df066d879c" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/b853ec27-702b-4be4-b439-a964e9ffd106" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP daytime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "281" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.210000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.050000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/362fb708-107d-4bf6-b69e-8eb3031e41a9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/6ee3d70f-d0f4-4d24-99f2-5b938d113121" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP mean trough (clinic, sitting)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "360" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.360000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "4.900000e-01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/362fb708-107d-4bf6-b69e-8eb3031e41a9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/6ee3d70f-d0f4-4d24-99f2-5b938d113121" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP mean trough (clinic, sitting)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "363" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.610000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "4.700000e-01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/362fb708-107d-4bf6-b69e-8eb3031e41a9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/6ee3d70f-d0f4-4d24-99f2-5b938d113121" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP mean trough (clinic, sitting)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "347" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.420000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "5.000000e-01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/362fb708-107d-4bf6-b69e-8eb3031e41a9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/6ee3d70f-d0f4-4d24-99f2-5b938d113121" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP mean trough (clinic, sitting)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "350" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.650000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "4.800000e-01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/362fb708-107d-4bf6-b69e-8eb3031e41a9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/6ee3d70f-d0f4-4d24-99f2-5b938d113121" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP mean trough (clinic, sitting)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "352" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.040000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "4.900000e-01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/362fb708-107d-4bf6-b69e-8eb3031e41a9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/6ee3d70f-d0f4-4d24-99f2-5b938d113121" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP mean trough (clinic, sitting)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "353" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.280000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "4.800000e-01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/40414760-115b-48e6-9d62-d5064dce631e" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/b974023f-34aa-4f43-bfad-fbc99a77ee38" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP nighttime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "223" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.340000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.660000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/40414760-115b-48e6-9d62-d5064dce631e" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/b974023f-34aa-4f43-bfad-fbc99a77ee38" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP nighttime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "290" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.490000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.680000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/40414760-115b-48e6-9d62-d5064dce631e" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/b974023f-34aa-4f43-bfad-fbc99a77ee38" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP nighttime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "227" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.330000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "6.740000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/40414760-115b-48e6-9d62-d5064dce631e" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/b974023f-34aa-4f43-bfad-fbc99a77ee38" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP nighttime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "278" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.580000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.670000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/40414760-115b-48e6-9d62-d5064dce631e" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/b974023f-34aa-4f43-bfad-fbc99a77ee38" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP nighttime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "219" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-9.600000e+00" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.730000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/40414760-115b-48e6-9d62-d5064dce631e" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/b974023f-34aa-4f43-bfad-fbc99a77ee38" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP nighttime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "281" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.180000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.720000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/9f6da480-7e22-40c4-8b3a-481a5a4122f9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/8794c190-f2fd-48c8-88ab-225dc15004cb" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "343" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "218" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/7434b44a-0b7c-49d8-bb68-fa1108e12665" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P14D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/9f6da480-7e22-40c4-8b3a-481a5a4122f9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/8794c190-f2fd-48c8-88ab-225dc15004cb" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "360" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "257" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/9f6da480-7e22-40c4-8b3a-481a5a4122f9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/8794c190-f2fd-48c8-88ab-225dc15004cb" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "362" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "282" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/8336c89f-30d4-4764-9e21-fc3672946f53" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P42D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/9f6da480-7e22-40c4-8b3a-481a5a4122f9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/8794c190-f2fd-48c8-88ab-225dc15004cb" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "363" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "290" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/9f6da480-7e22-40c4-8b3a-481a5a4122f9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/8794c190-f2fd-48c8-88ab-225dc15004cb" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "334" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "221" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/7434b44a-0b7c-49d8-bb68-fa1108e12665" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P14D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/9f6da480-7e22-40c4-8b3a-481a5a4122f9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/8794c190-f2fd-48c8-88ab-225dc15004cb" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "347" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "256" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/9f6da480-7e22-40c4-8b3a-481a5a4122f9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/8794c190-f2fd-48c8-88ab-225dc15004cb" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "350" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "269" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/8336c89f-30d4-4764-9e21-fc3672946f53" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P42D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/9f6da480-7e22-40c4-8b3a-481a5a4122f9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/8794c190-f2fd-48c8-88ab-225dc15004cb" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "350" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "277" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/9f6da480-7e22-40c4-8b3a-481a5a4122f9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/8794c190-f2fd-48c8-88ab-225dc15004cb" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "345" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "165" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/7434b44a-0b7c-49d8-bb68-fa1108e12665" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P14D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/9f6da480-7e22-40c4-8b3a-481a5a4122f9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/8794c190-f2fd-48c8-88ab-225dc15004cb" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "352" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "205" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/9f6da480-7e22-40c4-8b3a-481a5a4122f9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/8794c190-f2fd-48c8-88ab-225dc15004cb" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "353" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "236" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/8336c89f-30d4-4764-9e21-fc3672946f53" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P42D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/9f6da480-7e22-40c4-8b3a-481a5a4122f9" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/8794c190-f2fd-48c8-88ab-225dc15004cb" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "353" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "233" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/d8a5491c-77cc-4ace-8ebf-47152046dd29" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/491f1522-2f9b-41b5-98b7-d706f1aac75d" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP trough mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "223" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.340000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "9.860000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/d8a5491c-77cc-4ace-8ebf-47152046dd29" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/491f1522-2f9b-41b5-98b7-d706f1aac75d" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP trough mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "290" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.460000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "9.540000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/d8a5491c-77cc-4ace-8ebf-47152046dd29" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/491f1522-2f9b-41b5-98b7-d706f1aac75d" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP trough mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "227" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.460000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "9.940000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/d8a5491c-77cc-4ace-8ebf-47152046dd29" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/491f1522-2f9b-41b5-98b7-d706f1aac75d" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP trough mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "278" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.590000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "9.500000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/d8a5491c-77cc-4ace-8ebf-47152046dd29" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/491f1522-2f9b-41b5-98b7-d706f1aac75d" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP trough mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "219" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.090000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "9.920000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/d8a5491c-77cc-4ace-8ebf-47152046dd29" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/491f1522-2f9b-41b5-98b7-d706f1aac75d" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "DBP trough mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "281" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.200000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "9.550000e+00" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/0322f629-78c4-4450-a83b-5b206d73d44f" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/901fc3f7-655e-494e-a7c2-5b1521cdc41d" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP 12-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "223" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.500000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.299000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/0322f629-78c4-4450-a83b-5b206d73d44f" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/901fc3f7-655e-494e-a7c2-5b1521cdc41d" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP 12-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "290" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.710000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.311000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/0322f629-78c4-4450-a83b-5b206d73d44f" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/901fc3f7-655e-494e-a7c2-5b1521cdc41d" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP 12-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "227" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.550000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.296000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/0322f629-78c4-4450-a83b-5b206d73d44f" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/901fc3f7-655e-494e-a7c2-5b1521cdc41d" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP 12-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "278" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.880000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.301000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/0322f629-78c4-4450-a83b-5b206d73d44f" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/901fc3f7-655e-494e-a7c2-5b1521cdc41d" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP 12-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "219" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.920000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.302000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/0322f629-78c4-4450-a83b-5b206d73d44f" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/901fc3f7-655e-494e-a7c2-5b1521cdc41d" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP 12-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "281" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.110000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.308000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/f0a3b5d3-b7ec-4b61-9b72-2e4aa380d276" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/3f9b8db7-dcfb-492e-9a73-34f2c34e573e" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP 24-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "290" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.640000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.175000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/f0a3b5d3-b7ec-4b61-9b72-2e4aa380d276" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/3f9b8db7-dcfb-492e-9a73-34f2c34e573e" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP 24-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "223" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.410000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.210000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/92fb5983-9755-4c77-865d-7a7d62e8c22d" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/f0a3b5d3-b7ec-4b61-9b72-2e4aa380d276" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/3f9b8db7-dcfb-492e-9a73-34f2c34e573e" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP 24-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "278" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.790000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.167000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/f0a3b5d3-b7ec-4b61-9b72-2e4aa380d276" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/3f9b8db7-dcfb-492e-9a73-34f2c34e573e" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP 24-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "227" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.440000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.205000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/92fb5983-9755-4c77-865d-7a7d62e8c22d" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/f0a3b5d3-b7ec-4b61-9b72-2e4aa380d276" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/3f9b8db7-dcfb-492e-9a73-34f2c34e573e" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP 24-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "281" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.070000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.173000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/f0a3b5d3-b7ec-4b61-9b72-2e4aa380d276" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/3f9b8db7-dcfb-492e-9a73-34f2c34e573e" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP 24-hour mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "219" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.840000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.199000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/92fb5983-9755-4c77-865d-7a7d62e8c22d" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/cb27c3a2-4d85-44ad-a9ed-4b2383eff2bf" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5baadc13-6370-4d4d-980a-43b1a5404132" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP and DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "343" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "176" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/7434b44a-0b7c-49d8-bb68-fa1108e12665" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P14D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/cb27c3a2-4d85-44ad-a9ed-4b2383eff2bf" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5baadc13-6370-4d4d-980a-43b1a5404132" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP and DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "360" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "209" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/cb27c3a2-4d85-44ad-a9ed-4b2383eff2bf" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5baadc13-6370-4d4d-980a-43b1a5404132" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP and DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "362" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "249" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/8336c89f-30d4-4764-9e21-fc3672946f53" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P42D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/cb27c3a2-4d85-44ad-a9ed-4b2383eff2bf" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5baadc13-6370-4d4d-980a-43b1a5404132" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP and DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "363" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "252" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/cb27c3a2-4d85-44ad-a9ed-4b2383eff2bf" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5baadc13-6370-4d4d-980a-43b1a5404132" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP and DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "334" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "162" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/7434b44a-0b7c-49d8-bb68-fa1108e12665" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P14D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/cb27c3a2-4d85-44ad-a9ed-4b2383eff2bf" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5baadc13-6370-4d4d-980a-43b1a5404132" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP and DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "347" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "213" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/cb27c3a2-4d85-44ad-a9ed-4b2383eff2bf" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5baadc13-6370-4d4d-980a-43b1a5404132" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP and DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "350" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "229" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/8336c89f-30d4-4764-9e21-fc3672946f53" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P42D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/cb27c3a2-4d85-44ad-a9ed-4b2383eff2bf" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5baadc13-6370-4d4d-980a-43b1a5404132" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP and DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "350" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "241" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/cb27c3a2-4d85-44ad-a9ed-4b2383eff2bf" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5baadc13-6370-4d4d-980a-43b1a5404132" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP and DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "345" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "124" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/7434b44a-0b7c-49d8-bb68-fa1108e12665" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P14D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/cb27c3a2-4d85-44ad-a9ed-4b2383eff2bf" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5baadc13-6370-4d4d-980a-43b1a5404132" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP and DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "352" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "157" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/cb27c3a2-4d85-44ad-a9ed-4b2383eff2bf" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5baadc13-6370-4d4d-980a-43b1a5404132" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP and DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "353" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "196" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/8336c89f-30d4-4764-9e21-fc3672946f53" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P42D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/cb27c3a2-4d85-44ad-a9ed-4b2383eff2bf" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5baadc13-6370-4d4d-980a-43b1a5404132" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP and DBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "353" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "193" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/58278eeb-0f70-498f-800d-a4a897bbdb80" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/77267578-8aa8-4884-a4a3-5e9940e43bf1" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP daytime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "290" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.670000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.226000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/58278eeb-0f70-498f-800d-a4a897bbdb80" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/77267578-8aa8-4884-a4a3-5e9940e43bf1" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP daytime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "223" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.450000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.254000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/92fb5983-9755-4c77-865d-7a7d62e8c22d" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/58278eeb-0f70-498f-800d-a4a897bbdb80" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/77267578-8aa8-4884-a4a3-5e9940e43bf1" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP daytime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "278" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.840000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.234000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/58278eeb-0f70-498f-800d-a4a897bbdb80" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/77267578-8aa8-4884-a4a3-5e9940e43bf1" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP daytime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "227" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.510000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.251000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/92fb5983-9755-4c77-865d-7a7d62e8c22d" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/58278eeb-0f70-498f-800d-a4a897bbdb80" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/77267578-8aa8-4884-a4a3-5e9940e43bf1" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP daytime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "281" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.100000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.240000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/58278eeb-0f70-498f-800d-a4a897bbdb80" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/77267578-8aa8-4884-a4a3-5e9940e43bf1" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP daytime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "219" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.890000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.258000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/92fb5983-9755-4c77-865d-7a7d62e8c22d" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/23c58dc5-5b80-4ae4-bac5-f7a92f2def53" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/da485445-3313-421f-993c-0872caf19607" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP mean trough (clinic, sitting)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "360" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-3.300000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.700000e-01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/23c58dc5-5b80-4ae4-bac5-f7a92f2def53" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/da485445-3313-421f-993c-0872caf19607" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP mean trough (clinic, sitting)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "363" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-3.760000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.300000e-01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/23c58dc5-5b80-4ae4-bac5-f7a92f2def53" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/da485445-3313-421f-993c-0872caf19607" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP mean trough (clinic, sitting)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "347" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-3.410000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.800000e-01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/23c58dc5-5b80-4ae4-bac5-f7a92f2def53" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/da485445-3313-421f-993c-0872caf19607" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP mean trough (clinic, sitting)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "350" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-3.820000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.500000e-01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/23c58dc5-5b80-4ae4-bac5-f7a92f2def53" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/da485445-3313-421f-993c-0872caf19607" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP mean trough (clinic, sitting)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "352" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.690000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.800000e-01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/23c58dc5-5b80-4ae4-bac5-f7a92f2def53" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/da485445-3313-421f-993c-0872caf19607" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP mean trough (clinic, sitting)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "353" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-3.150000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "8.400000e-01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf77eaf0-98ae-42d3-a485-a484b8e98f24" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/2ce0c8a2-b5e5-485e-b56d-47ed2da0d821" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP nighttime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "223" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.230000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.299000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf77eaf0-98ae-42d3-a485-a484b8e98f24" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/2ce0c8a2-b5e5-485e-b56d-47ed2da0d821" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP nighttime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "290" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.520000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.260000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf77eaf0-98ae-42d3-a485-a484b8e98f24" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/2ce0c8a2-b5e5-485e-b56d-47ed2da0d821" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP nighttime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "227" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.190000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.296000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf77eaf0-98ae-42d3-a485-a484b8e98f24" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/2ce0c8a2-b5e5-485e-b56d-47ed2da0d821" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP nighttime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "278" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.630000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "7.500000e-01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf77eaf0-98ae-42d3-a485-a484b8e98f24" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/2ce0c8a2-b5e5-485e-b56d-47ed2da0d821" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP nighttime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "219" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.660000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.302000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf77eaf0-98ae-42d3-a485-a484b8e98f24" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/2ce0c8a2-b5e5-485e-b56d-47ed2da0d821" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP nighttime mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "281" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.970000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.257000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/205912d0-e51e-4313-8484-95e22fd5d086" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/89396b2e-ef67-465a-9c09-9fc4babff953" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "343" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "207" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/7434b44a-0b7c-49d8-bb68-fa1108e12665" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P14D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/205912d0-e51e-4313-8484-95e22fd5d086" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/89396b2e-ef67-465a-9c09-9fc4babff953" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "360" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "238" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/205912d0-e51e-4313-8484-95e22fd5d086" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/89396b2e-ef67-465a-9c09-9fc4babff953" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "362" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "278" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/8336c89f-30d4-4764-9e21-fc3672946f53" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P42D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/205912d0-e51e-4313-8484-95e22fd5d086" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/89396b2e-ef67-465a-9c09-9fc4babff953" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "363" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "276" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/205912d0-e51e-4313-8484-95e22fd5d086" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/89396b2e-ef67-465a-9c09-9fc4babff953" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "334" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "191" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/7434b44a-0b7c-49d8-bb68-fa1108e12665" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P14D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/205912d0-e51e-4313-8484-95e22fd5d086" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/89396b2e-ef67-465a-9c09-9fc4babff953" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "347" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "239" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/205912d0-e51e-4313-8484-95e22fd5d086" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/89396b2e-ef67-465a-9c09-9fc4babff953" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "350" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "257" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/8336c89f-30d4-4764-9e21-fc3672946f53" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P42D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/205912d0-e51e-4313-8484-95e22fd5d086" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/89396b2e-ef67-465a-9c09-9fc4babff953" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "350" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "266" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/205912d0-e51e-4313-8484-95e22fd5d086" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/89396b2e-ef67-465a-9c09-9fc4babff953" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "345" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "155" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/7434b44a-0b7c-49d8-bb68-fa1108e12665" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P14D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/205912d0-e51e-4313-8484-95e22fd5d086" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/89396b2e-ef67-465a-9c09-9fc4babff953" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "352" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "184" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/205912d0-e51e-4313-8484-95e22fd5d086" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/89396b2e-ef67-465a-9c09-9fc4babff953" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "353" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "229" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/8336c89f-30d4-4764-9e21-fc3672946f53" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P42D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/205912d0-e51e-4313-8484-95e22fd5d086" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/89396b2e-ef67-465a-9c09-9fc4babff953" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP response (clinic)" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "353" } ,
        "count": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "228" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/f62cc5a6-7044-4386-8592-64304c9bcc0d" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5f7e074a-9fce-49b6-b99c-fbd7767c915b" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP trough mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "223" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.240000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.419000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/f62cc5a6-7044-4386-8592-64304c9bcc0d" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5f7e074a-9fce-49b6-b99c-fbd7767c915b" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP trough mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/a8f1626d-f34d-4895-b5d7-ab000a19453d" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "290" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.490000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.345000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/f62cc5a6-7044-4386-8592-64304c9bcc0d" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5f7e074a-9fce-49b6-b99c-fbd7767c915b" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP trough mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "227" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.360000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.416000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/f62cc5a6-7044-4386-8592-64304c9bcc0d" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5f7e074a-9fce-49b6-b99c-fbd7767c915b" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP trough mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/bf34362a-c4e9-430c-b648-15eee9c3b0ef" } ,
        "groupLabel": { "type": "literal" , "value": "Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "278" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-2.680000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.351000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/f62cc5a6-7044-4386-8592-64304c9bcc0d" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5f7e074a-9fce-49b6-b99c-fbd7767c915b" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP trough mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "219" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.740000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.421000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/c8db670a-981b-4b4a-a2da-90fc14ed3b0f" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochStart" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "P28D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      } ,
      {
        "outcomeUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/f62cc5a6-7044-4386-8592-64304c9bcc0d" } ,
        "studyDataTypeUri": { "type": "uri" , "value": "http://trials.drugis.org/entities/5f7e074a-9fce-49b6-b99c-fbd7767c915b" } ,
        "studyDataTypeLabel": { "type": "literal" , "value": "SBP trough mean" } ,
        "instanceUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/5959fd08-9c5b-4016-8118-d195cdb80c70" } ,
        "groupLabel": { "type": "literal" , "value": "Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD" } ,
        "isArm": {"value": "true"},
        "sampleSize": { "datatype": "http://www.w3.org/2001/XMLSchema#integer" , "type": "typed-literal" , "value": "281" } ,
        "mean": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "-1.960000e+01" } ,
        "std": { "datatype": "http://www.w3.org/2001/XMLSchema#double" , "type": "typed-literal" , "value": "1.341000e+01" } ,
        "momentUid": { "type": "uri" , "value": "http://trials.drugis.org/instances/3fbe679f-c097-49b4-8245-f3c6f9f6e1c0" } ,
        "relativeToAnchor": { "type": "uri" , "value": "http://trials.drugis.org/ontology#anchorEpochEnd" } ,
        "timeOffset": { "datatype": "http://www.w3.org/2001/XMLSchema#duration" , "type": "typed-literal" , "value": "-P0D" } ,
        "duration": { "type": "literal" , "value": "P56D" } ,
        "relativeToEpochLabel": { "type": "literal" , "value": "Main phase" }
      }
    ]
  }
}
